CV Sciences (CVSI) Research & Development (2013 - 2026)
CV Sciences (CVSI) posted Research & Development of $18000.0 for Q1 2026, little changed sequentially from $18000.0 in Q4 2025, and down 40.0% YoY from $30000.0 in Q1 2025.
CV Sciences (CVSI) Research & Development (2013 - 2026) Analysis & Trends
CV Sciences has reported Research & Development for 14 years, with the latest figure at $18000.0 in Q1 2026.
- Quarterly Research & Development fell 40.0% year-over-year to $18000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $110000.0 (down 1.79% YoY) and the FY2025 annual result came in at $122000.0, up 3.39% from the prior year.
- Research & Development was little changed at $18000.0 in Q1 2026 per CVSI's latest filing, from $18000.0 in the prior quarter.
- Over five years, Research & Development peaked at $121000.0 in Q1 2022 and troughed at $18000.0 in Q4 2025.
- A 5-year average of $42117.6 and a median of $36000.0 in 2023 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2025: Research & Development slumped 89.27% in 2022, then surged 78.57% in 2025.
- Over 5 years, Research & Development stood at $40000.0 in 2022, then changed by 0.0% to $40000.0 in 2023, then plunged by 37.5% to $25000.0 in 2024, then slipped by 28.0% to $18000.0 in 2025, then changed by 0.0% to $18000.0 in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $18000.0, $18000.0, and $24000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | 18,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18,000.00 |
| Mar 31, 2026 | 18,000.00 |
| Dec 31, 2025 | 18,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 50,000.00 |
| Mar 31, 2025 | 30,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | 36,000.00 |
| Dec 31, 2023 | 40,000.00 |
| Sep 30, 2023 | 40,000.00 |
| Jun 30, 2023 | 36,000.00 |
| Mar 31, 2023 | 35,000.00 |
| Dec 31, 2022 | 40,000.00 |
| Sep 30, 2022 | 44,000.00 |
| Jun 30, 2022 | 102,000.00 |
| Mar 31, 2022 | 121,000.00 |
| Dec 31, 2021 | 364,000.00 |
| Sep 30, 2021 | 410,000.00 |